BRILIFE Trademark

Trademark Overview


On Wednesday, November 17, 2021, a trademark application was filed for BRILIFE with the United States Patent and Trademark Office. The USPTO has given the BRILIFE trademark a serial number of 79329259. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, May 11, 2023. This trademark is owned by State of Israel, Israel Institute for Biological Research. The BRILIFE trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines
brilife

General Information


Serial Number79329259
Word MarkBRILIFE
Filing DateWednesday, November 17, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, May 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesVaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 3, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameState of Israel, Israel Institute for Biological Research
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIL

Trademark Events


Event DateEvent Description
Monday, January 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 23, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, January 7, 2022APPLICATION FILING RECEIPT MAILED
Saturday, September 3, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, October 27, 2022REFUSAL PROCESSED BY MPU
Friday, October 28, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, May 11, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, August 29, 2022ASSIGNED TO EXAMINER
Friday, September 2, 2022NON-FINAL ACTION WRITTEN
Monday, November 21, 2022REFUSAL PROCESSED BY IB
Thursday, May 11, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, May 11, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, May 24, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Saturday, May 11, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sunday, June 2, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, May 13, 2024FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, May 24, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, June 12, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Related Keywords


brilife vaccines